In a report released yesterday, David Windley from Jefferies maintained a Buy rating on IQVIA Holdings (IQV – Research Report), with a price target of $266.00.
David Windley has given his Buy rating due to a combination of factors including IQVIA Holdings’ stable performance and anticipated growth in specific business segments. The first quarter’s results were largely as anticipated, with Research and Development Solutions (R&DS) showing solid mid-single-digit growth excluding COVID-related activities. Despite current challenges in the Technology & Analytics Solutions (TAS) segment due to sponsor budget caution, there is potential for a strong rebound in the second half of the year. This optimism is bolstered by a significant new contract win in the Customer Relationship Management (CRM) business, suggesting an increasing momentum that could contribute to improved financials.
Furthermore, Windley notes the healthy increase in request for proposals (RFPs), particularly from large pharmaceutical companies, indicating a resilient demand for IQVIA’s services. The biotech funding environment remains robust, which could support stronger bookings in the second half of the year. Positive developments in IQVIA’s CRM offerings, including the expansion of its partnership with Salesforce, are expected to enhance its competitive edge. Overall, Windley’s Buy rating reflects confidence in the company’s ability to leverage these positive trends and achieve significant margin expansion in the latter part of the year.
In another report released today, Truist Financial also maintained a Buy rating on the stock with a $292.00 price target.
IQV’s price has also changed moderately for the past six months – from $190.460 to $222.140, which is a 16.63% increase.
TipRanks tracks over 100,000 company insiders, identifying the select few who excel in timing their transactions. By upgrading to TipRanks Premium, you will gain access to this exclusive data and discover crucial insights to guide your investment decisions. Begin your TipRanks Premium journey today.
IQVIA Holdings (IQV) Company Description:
North Carolina-based IQVIA Holdings, Inc. provides advanced analytics, technology solutions, and contract research services to the life sciences industry. The company operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.
